# 該公司必須涵蓋這五項評級中的至少四項，才能進行計算。

*biotech · news · 2026-03-23 · MarketScreener*

## Key points

- Trader 超級評級整合了全球估值、4 個月內的每股盈餘修正及能見度指標。
- Investor 超級評級獨特地包含了 1 年的每股盈餘修正以及其他綜合財務指標。
- 全球綜合評級要求至少涵蓋五項特定財務評級中的四項。
- 品質綜合評級需要至少涵蓋資本效率、報告品質和財務健康中的兩項。

Trader This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions. Investor This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions. Global This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions. Quality This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

[Read the full story on MarketScreener](https://www.marketscreener.com/news/gsk-s-antibody-drug-conjugate-for-small-cell-lung-cancer-secures-orphan-drug-designation-in-japan-ce7e5edcdd8ef623)

---

Canonical: https://newsio.io/zh-TW/n/5f0c5ed6-097b-41db-986f-8d9732f3c909/
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works